Advantest (6857): The 2026 Hub Analysis for Semiconductors & Materials

Every time I pull up Advantest’s Japanese-language IR briefing slides — the ones that never get fully translated for English-speaking investors — I’m struck by how much management reveals in the Q&A that the press releases quietly omit: order backlog composition, capacity utilisation commentary, and which chipmaker segments are accelerating. That granularity is exactly why I wanted to write this piece now, with FY2026 record results freshly published and the 10,000-system capacity announcement still being digested by the market.

Advantest (TSE: 6857) is not a household name for most US investors — but it probably should be. This article is the pillar hub for the Semiconductors & Materials cluster on Best Japan Stocks, and Advantest earns that anchor position: it is the world’s leading maker of automatic test equipment (ATE) for advanced semiconductors, and its FY2026 results were the most compelling earnings print I have seen from a Japanese technology company in years. What follows is a comprehensive analysis — financials, catalysts, governance, employee culture, and risks — framed for a US-based dividend and value investor deciding whether to allocate to this name.

Disclosure: This article is for informational purposes only and does not constitute investment advice. See full Disclaimer below.

Metric	Value (as of May 29, 2026)
Stock Price (JPY)	¥26,170
Market Cap	¥19.16 trillion
Forward Dividend Yield	~0.39%
Payout Ratio (FY2025)	17.8%
P/E Ratio (TTM)	40.8x
P/B Ratio (TTM)	24.48x
FY2026 Revenue (YoY)	¥1,128.6B (+44.7%)
FY2026 Operating Profit (YoY)	¥499.1B (+118.8%)
Basic EPS (FY2026)	¥515.15
TSE Listing	Prime Market
みんかぶ Consensus Target	¥32,695 (+24.9% upside)
Morningstar Fair-Value Estimate	¥34,000

Why Semiconductor Testing Is the Invisible Toll Booth of the AI Era

Most coverage of the AI semiconductor boom focuses on chip designers (NVIDIA, AMD) or foundries (TSMC, Samsung). The test equipment layer — the machinery that verifies every chip works correctly before it ships — receives a fraction of the attention despite being entirely non-discretionary spend.

No chip leaves a fab without passing an ATE gauntlet. As chips grow more complex — more transistors, more interconnect layers, more heterogeneous integration — the test time per chip and the sophistication of the test system required both increase. This is a structural tailwind, not a cyclical one.

From Logic to Memory — Why Every Chip Needs a Test Pass

The ATE market broadly splits into two domains: SoC (System-on-Chip) testers for logic and mixed-signal devices, and memory testers for DRAM, NAND, and increasingly HBM (High Bandwidth Memory). Teradyne, Advantest’s closest global rival, is strongest in SoC and wireless. Advantest has historically dominated memory ATE and has been aggressively expanding its SoC share.

This dual exposure is critical for the AI era. AI accelerators like NVIDIA’s H100 and B200 require both SoC testing (for the logic die) and HBM testing (for the stacked memory). Advantest is one of the few equipment makers positioned to capture both test steps in a single customer relationship.

AI, HPC, 5G, and IoT are collectively driving demand for higher-performance chips with tighter quality tolerances. The yield economics at 3nm and below make thorough testing economically essential — a defective chip in an AI server costs far more in downtime than the test equipment amortised over its lifetime.

Advanced Packaging as a New Testing Frontier

The shift to advanced packaging — 3D-IC stacking, chiplet architectures, co-packaged optics — creates entirely new test challenges that legacy equipment cannot address. A chiplet package from AMD or Intel contains multiple dies from different foundries, each requiring individual known-good-die (KGD) testing before assembly, plus system-level testing after integration.

This multiplies the number of test touchpoints per finished device. For Advantest, it means higher revenue per chip shipped — a structural upgrade to the revenue model that has no historical precedent in the ATE industry.

A Japan-specific angle that English-language coverage consistently misses: METI’s semiconductor industry roadmap (経済産業省 半導体・デジタル産業戦略) explicitly identifies domestic ATE capability as a national priority. Advantest, as a TSE Prime-listed Japanese champion in ATE, benefits from policy tailwinds — subsidies, preferential procurement signals, and export licensing alignment — that are documented in Japanese-language METI publications but rarely surface in English-language analyst reports.

Adjacent Japanese players Tokyo Electron (8035) and Micronics Japan (6871) operate in related equipment niches, but neither has Advantest’s specific dominance in the test layer. Tokyo Electron’s portfolio is broader (coaters, etchers, thermal processing); Advantest’s specialisation in ATE is its competitive moat.

FY2026 Record Results — Dissecting the Numbers Behind the Headlines

Advantest’s FY2026 results (fiscal year ended March 2026) were not merely strong — they represented a step-change in the company’s earnings power. The headline numbers are available in English, but the quality of the earnings — the operating leverage, the margin structure, the EPS trajectory — deserves careful unpacking.

Full-year revenue came in at ¥1,128.6 billion, up 44.7% year-over-year. Operating profit reached ¥499.1 billion, up 118.8% YoY. Net profit attributable to parent shareholders was ¥375.4 billion, up 132.9% YoY. Basic EPS was ¥515.15. These figures are sourced directly from Advantest’s official Japanese-language IR quarterly results page.

Operating Leverage in Action — How Margins More Than Doubled

The most important story in the FY2026 print is operating leverage. Revenue grew 44.7%, but operating profit grew 118.8%. That asymmetry reveals a business model with significant fixed-cost leverage — once the R&D and manufacturing infrastructure is in place, incremental revenue flows through to profit at a dramatically higher rate.

Net margin reached approximately 33% for the full year (¥375.4B net profit on ¥1,128.6B revenue). For context, this is a margin profile that rivals the best software businesses in the US — exceptional for a hardware manufacturer. The Q4 standalone quarter (January–March 2026) delivered revenue of ¥328.07 billion and EPS of ¥174.55, both exceeding analyst forecasts per Investing.com’s earnings history.

For US investors accustomed to comparing semiconductor equipment names: Advantest’s 33% net margin in FY2026 compares favourably to Teradyne’s typical mid-20s net margin range. The operating leverage differential is a key reason why Advantest commands a premium multiple.

EPS and Payout Ratio — The Dividend Growth Runway

Advantest is not a dividend stock today. The forward yield of approximately 0.39% will not attract income-focused investors in the near term. But the payout ratio of 17.8% in FY2025 — against an EPS of ¥515.15 in FY2026 — reveals a significant dividend growth optionality that the current yield obscures.

If Advantest were to normalise its payout ratio toward 30–40% (consistent with mature Japanese technology companies), the implied dividend at FY2026 EPS levels would be ¥154–¥206 per share annually. That would represent a yield of approximately 0.6–0.8% at the current price — still modest by dividend-investor standards, but the trajectory matters more than the starting point.

The honest framing for dividend-focused readers: position Advantest as a growth-with-governance compounder, not a current-income play. The dividend growth runway is real, but it is a 3–5 year story, not a 12-month income solution.

Valuation Check — Is 40.8x PER Defensible?

At 40.8x trailing earnings and 24.48x book value, Advantest is priced for continued hyper-growth. The PBR figure alone would trigger alarm bells under the TSE’s governance reform push — except that Advantest’s high PBR reflects genuine earnings power, not balance sheet bloat. This is a quality compounder above book, not a low-PBR value trap.

The valuation is defensible IF: (1) AI chip capex by hyperscalers continues at current or accelerating rates; (2) the capacity build-out to 10,000 systems executes on schedule; and (3) no material earnings miss occurs in FY2027. All three are reasonable base-case assumptions — but none is guaranteed. The Morningstar fair-value estimate of ¥34,000 implies approximately 30% upside from the ¥26,170 May 29 close, suggesting the premium is not yet fully priced in at current levels.

Capacity Expansion to 10,000 Systems and the AI Demand Supercycle

The most consequential announcement from Advantest’s April 29, 2026 earnings release was not the record FY2026 numbers — it was the forward-looking capacity commitment. Management announced plans to expand annual production capacity to 10,000 test systems by the end of 2028, nearly doubling from current run-rates.

The 10,000-System Target — What It Means for Revenue Capacity

A back-of-envelope revenue potential calculation: if Advantest’s FY2026 revenue of ¥1,128.6B was generated at approximately 5,000–6,000 systems annually (implied by capacity utilisation commentary in the Japanese-language IR briefings), then 10,000 systems at similar average selling prices implies a revenue capacity ceiling in the ¥1.8–2.2 trillion range at full utilisation.

That ceiling is not a FY2027 event — it is a FY2028/2029 story. But it establishes a credible multi-year revenue growth runway that justifies paying a premium multiple today. The capacity investment is also a signal: management would not commit to this scale of build-out without visibility into customer order intent from major chipmakers.

The full announcement details are available on Advantest’s Japanese-language investor news page, which contains management commentary not fully replicated in English press releases. I track the dividend and price history on TradingView alongside these IR releases to cross-reference the market’s reaction to each announcement.

Analyst Upgrade Cluster — When Nomura, Morningstar, and US Brokers Align

The convergence of domestic and foreign analyst upgrades in May 2026 is a meaningful signal. Nomura Securities raised its fair-value estimate to ¥30,600 with a “Buy” rating on May 20, 2026, citing strong Q4 FY2026 demand and accelerated capacity expansion plans. Morningstar raised its fair-value estimate to ¥34,000 on May 28, 2026. A major US brokerage set a ¥36,000 fair-value estimate with a “Strong Buy” equivalent stance on May 27, 2026, per みんかぶ’s domestic analyst consensus tracker.

The みんかぶ domestic consensus as of May 29, 2026: 9 strong buy, 7 buy, 4 neutral — zero sell ratings. Average consensus fair-value estimate ¥32,695, implying +24.93% upside from ¥26,170. This domestic Japanese sell-side conviction is a data point that English-language aggregators like Bloomberg consensus often lag in incorporating, because domestic analysts track Advantest’s order intake from Japanese chipmakers (Kioxia, Renesas) more granularly than their international counterparts.

The share repurchase program announced May 29, 2026, and the RSU-based treasury stock disposal on May 27, 2026, are additional capital return signals. Management is simultaneously investing in growth capacity AND returning capital — a combination that suggests confidence in the earnings trajectory.

TSE Governance Reforms and Advantest’s Shareholder Return Framework

Japan’s corporate governance reform story is one of the most significant structural changes in Asian equity markets over the past decade — and it is still underway. The Tokyo Stock Exchange and Financial Services Agency have been pressuring listed companies to improve capital efficiency, address low PBRs, and enhance shareholder returns. Revisions to Japan’s Corporate Governance Code are expected in June 2026, with a focus on minority shareholder protections and cash allocation discipline.

For most Japanese companies, governance reform is a “rescue mechanism” — a push to unlock value trapped in bloated balance sheets and cross-shareholding structures. Advantest’s situation is fundamentally different.

Share Buybacks as a Capital Efficiency Signal

Advantest’s PBR of 24.48x means it is not a low-PBR value trap requiring rescue. It is a high-quality compounder already trading at a substantial premium to book, reflecting genuine earnings power. The TSE governance reform tailwind for Advantest is therefore qualitative rather than balance-sheet mechanical: it signals that Japanese boards are increasingly aligned with shareholder interests, and Advantest’s management is demonstrating that alignment proactively.

The May 29, 2026 share repurchase announcement and the May 27, 2026 RSU treasury stock disposal are concrete evidence of this alignment. Share buybacks reduce the denominator for EPS calculations and signal management’s confidence that the stock is not overvalued at current levels. The ClearBridge Investments analysis of Japan’s governance reforms provides useful English-language context for how these structural changes are being interpreted by international institutional investors.

Dividend Growth Potential — The 17.8% Payout Ratio Opportunity

The FSA’s Japanese-language Corporate Governance Code revision discussion papers (金融庁 コーポレートガバナンス・コード) outline specific ROE and PBR thresholds that boards are being pressured to meet. Advantest’s implied ROE — derived from its PBR of 24.48x and the earnings trajectory — already substantially exceeds the typical TSE reform targets (ROE above 8% is the standard benchmark; Advantest’s ROE is well into double digits).

This means governance reform is a tailwind for Advantest’s quality positioning, not a prerequisite for its investment case. The payout ratio of 17.8% leaves substantial room for dividend increases as earnings compound. A normalisation toward 30–40% payout — consistent with where Japanese technology companies have been trending under governance pressure — represents a meaningful dividend growth catalyst over the next 3–5 years.

Employee Quality and Operational Moat — What OpenWork Scores Reveal

Institutional research rarely quantifies the quality of a company’s human capital. For a specialised engineering firm like Advantest, where the core product is built on decades of accumulated test algorithm expertise, employee quality and retention are not soft metrics — they are competitive moat indicators.

Why ATE Engineering Talent Is a Competitive Moat

Advantest’s overall employee rating on OpenWork.jp is 4.3 out of 5.0, based on 499 reviews. The standout sub-scores are Employee Mutual Respect at 5.0/5.0, Compliance Awareness at 5.0/5.0, and Long-term Talent Development at 4.0/5.0.

OpenWork.jp (オープンワーク) is a Japanese-language employee review platform that functions similarly to Glassdoor but with deeper penetration among Japanese engineering professionals. It is not indexed in English-language searches, which means the data is invisible to most US-based analysts — a genuine information edge for Tokyo-based investors who can read the reviews directly.

The 5.0/5.0 compliance score is particularly notable given Japan’s tightening semiconductor export control environment. METI export licensing requirements for advanced ATE are increasingly stringent; a company with perfect compliance scores is operationally better positioned to navigate these requirements without disruption.

ATE test engineers are among the most specialised professionals in the semiconductor ecosystem. They understand not just the hardware but the test algorithms, fault models, and yield optimisation logic specific to each chip architecture. This knowledge does not transfer easily between companies — retention of these engineers is IP retention. An employee satisfaction score of 4.3/5.0 in this context is a meaningful competitive moat indicator.

Advantest employs approximately 7,000 people globally against a market cap of ¥19.16 trillion. That implies revenue per employee of approximately ¥161 million (¥1,128.6B / 7,000) — an extraordinarily high productivity ratio that reflects the capital-intensive, high-ASP nature of the ATE business.

Reading the Pre-2020 Restructuring Signal

Some older OpenWork reviews (pre-2020) mention concerns about restructuring and excellent employees departing. Rather than dismissing these, I read them as evidence of management’s willingness to make hard structural decisions when necessary — the same quality that enabled the dramatic margin improvement visible in FY2026 results.

A company that restructured proactively in lean years and then delivered 118.8% operating profit growth in FY2026 is demonstrating exactly the kind of management adaptability that long-term investors should value. The current high employee scores likely reflect the cultural improvement that followed that restructuring period.

Risks and Counter-View — Where the Bull Case Can Break

Advantest’s bull case is compelling — but three specific risks deserve serious consideration before sizing a position. These are not generic disclaimers; they are grounded in the specific dynamics of Advantest’s FY2027 guidance and the macro environment.

Risk 1 — Flat FY2027 Operating Margin Guidance

Management guided for flat operating margins in FY2027 alongside the April 29, 2026 Q4 beat. This is the most important near-term risk. The cost of building toward 10,000 systems annually — factory expansion, equipment procurement, hiring and training specialised engineers — will absorb a significant portion of incremental revenue in FY2027.

If AI capex by hyperscalers (the customers of NVIDIA, AMD, and other AI chip designers) moderates — whether due to macro slowdown, AI hype cycle normalisation, or regulatory pressure — Advantest could find itself with elevated fixed costs and softer-than-expected order flow. This is the classic semiconductor equipment cycle trap: capacity built at the top of the cycle becomes a liability if demand pauses.

Japanese domestic retail investors on Yahoo!ファイナンス掲示板 and みんかぶ boards have been actively discussing this FY2027 margin guidance concern — domestic investors who track Advantest’s quarterly order intake from Japanese IR briefings are more attuned to the order-to-revenue lag dynamics than English-language coverage typically reflects.

Risk 2 — Geopolitical and Export Control Exposure

US-China semiconductor trade restrictions and Japan’s own export control tightening — METI export licensing for advanced semiconductor equipment — could restrict Advantest’s addressable market in China. China has historically been a significant ATE buyer; any escalation in US-Japan-China tech trade tensions could reduce order flow materially.

Japan’s export control regime for semiconductor equipment has been progressively tightened since 2023. Advantest’s 5.0/5.0 compliance score on OpenWork suggests the company is managing this well operationally, but the market risk of further restrictions is real and not fully quantifiable from public disclosures.

Risk 3 — Multiple Compression Scenario at 40.8x PER

At 40.8x trailing earnings, Advantest is priced for continued hyper-growth. The stock’s post-earnings dip on April 29, 2026 — despite beating Q4 forecasts — illustrates precisely how quickly sentiment can reverse when guidance disappoints at these multiples.

A re-rating from 40.8x to 30x PER — still a premium multiple, but reflecting normalised rather than hyper-growth expectations — would imply a stock price of approximately ¥19,200 (¥515.15 EPS × 30x = ¥15,455 on FY2026 EPS, or approximately ¥19,000–20,000 on forward EPS estimates). That represents a 25–30% drawdown from current levels. Investors should size positions with this scenario explicitly modelled.

The Google Finance data page for Advantest (6857:TYO) provides a useful real-time reference for tracking multiple evolution against earnings revisions.

Advantest vs. US Semiconductor Equipment Peers — Portfolio Context

For US investors evaluating Advantest as a portfolio addition, the relevant comparison is not to Japanese dividend stalwarts like NTT or KDDI — it is to US semiconductor equipment names like Teradyne (TER), KLA Corporation (KLAC), and Lam Research (LRCX).

Teradyne, Advantest’s closest direct competitor, trades at approximately 25–30x forward earnings with a dividend yield around 0.5–0.7%. Advantest’s 40.8x PER reflects its higher growth rate and memory ATE dominance — but also a meaningful valuation premium that requires sustained outperformance to justify.

For an IRA or taxable brokerage account, Advantest is best positioned as a growth allocation within the technology sleeve — not as a dividend replacement. The JPY/USD currency exposure is a real consideration: a 10% yen depreciation would reduce USD-denominated returns by approximately 10% on dividends and capital gains alike. Investors who are already long JPY through other Japan positions may find this exposure additive rather than duplicative.

If you are building a Japan semiconductor basket, Advantest pairs well with materials plays in the same supply chain. Our analysis of Shin-Etsu Chemical (4063) at 2.18% yield covers the silicon wafer and specialty chemicals layer that feeds into the fabs whose chips Advantest then tests — a complementary exposure with a more income-oriented profile. For a pure-play equipment angle closer to Advantest’s segment, see our deep-dive on Disco Corp. (6146), which dominates precision dicing and grinding equipment for the same advanced packaging trends driving Advantest’s growth.

Company	Ticker	P/E (TTM)	Fwd Yield	FY Revenue Growth	Key ATE Segment
Advantest	6857 (TSE)	40.8x	~0.39%	+44.7% (FY2026)	Memory + SoC ATE
Teradyne	TER (NASDAQ)	~27x	~0.6%	Mid-single digits	SoC + Wireless ATE
FormFactor	FORM (NASDAQ)	~22x	None	Mid-single digits	Probe cards
Cohu	COHU (NASDAQ)	~18x	None	Modest	Handlers + ATE

Peer P/E and yield figures are approximate and for illustrative comparison only. Verify current data via TradingView or your broker’s research tools before making allocation decisions.

Bottom Line — Advantest as the Pillar Holding for Japan Semiconductor Exposure

Advantest is not the Japan semiconductor story most US investors think they want — a cheap, high-yield, value-unlocking play. It is something rarer and more valuable: a structurally dominant technology company at the centre of the AI chip supply chain, with record earnings, a credible multi-year capacity roadmap, and a governance framework that is becoming progressively more shareholder-friendly.

The dual fair-value anchors — Morningstar’s ¥34,000 and みんかぶ’s domestic consensus ¥32,695 — both imply 24–30% upside from the May 29, 2026 close of ¥26,170. The post-earnings dip on conservative FY2027 margin guidance created exactly the kind of sentiment-driven entry point that patient investors should welcome.

My honest assessment: Advantest earns a constructive stance as the pillar holding for Japan semiconductor exposure precisely because it sits at the intersection of every major chip technology trend — AI accelerators, HBM memory, advanced packaging — and has the capacity build-out plan to prove it is not merely riding the wave but actively expanding to capture it.

The near-term monitoring catalyst is clear: FY2027 Q1 results (expected July 2026) will reveal whether order intake is tracking ahead of or behind the capacity expansion timeline. That data point — specifically the order backlog composition between memory and SoC segments — will be the most important signal for validating or revising the thesis. Watch for the Japanese-language 決算説明資料 (earnings briefing materials) on the official IR page for the segment-level commentary that the English press release will not provide.

For readers building a Japan semiconductor basket: Advantest as the growth engine, Shin-Etsu Chemical as the materials anchor, and Disco Corp. as the precision equipment complement — that three-stock framework covers the test, materials, and processing layers of the AI chip supply chain with meaningful differentiation between positions.

Frequently Asked Questions

Q: What is Advantest’s current dividend yield, and is it suitable for income investors?

Advantest’s forward dividend yield is approximately 0.39% at the May 2026 price of ¥26,170. The payout ratio was 17.8% in FY2025 against FY2026 EPS of ¥515.15, which means the company is retaining the vast majority of its earnings for reinvestment and buybacks. This is not a current-income stock. The investment case is capital appreciation and dividend growth optionality over a 3–5 year horizon as the payout ratio normalises toward 30–40%.

Q: How much Japanese withholding tax will I pay on Advantest dividends as a US investor?

Under the US-Japan tax treaty, Japanese dividend withholding is 15% for US investors (the standard treaty rate that brokers apply). You can claim this as a foreign tax credit on IRS Form 1116, effectively recovering it against your US tax liability if you have sufficient foreign income. The actual withholding applied at source is typically 15.315% (15% national tax plus 0.315% reconstruction surtax). Note that at Advantest’s current 0.39% yield, the after-withholding dividend income is minimal — the tax efficiency question matters more if the payout ratio increases substantially in future years.

Q: Can I buy Advantest (6857) through my US brokerage account?

Yes. Advantest trades on the Tokyo Stock Exchange Prime Market under ticker 6857. There is no sponsored ADR program, so US investors must access it via direct TSE trading. Interactive Brokers (IBKR) provides direct TSE access with competitive JPY/USD spreads and is the most straightforward option for US-based investors. Saxo Bank is preferred for Singapore and European-based readers. Webull offers growing TSE coverage at lower minimums. Fidelity and Schwab do not currently offer direct TSE trading for retail accounts.

Q: What is the biggest risk to the Advantest investment thesis in the next 12 months?

The most specific near-term risk is the combination of flat FY2027 operating margin guidance and the 40.8x PER valuation. If hyperscaler AI capex moderates — reducing demand for advanced chips and therefore for ATE — Advantest could face both an earnings miss and a multiple de-rating simultaneously. A compression from 40.8x to 30x PER alone would imply a 25–30% price decline even without an EPS cut. The FY2027 Q1 order intake data (July 2026) is the key near-term signal to watch.

Q: Why should I trust analysis based on Japanese-language sources I can’t read myself?

Fair question. Every Japanese-language source cited in this article is linked directly so you can verify via machine translation (DeepL handles Japanese IR materials well). The specific data points cited — みんかぶ consensus figures, OpenWork scores, Advantest IR commentary — are factual data that can be independently confirmed. The edge is not in claiming exclusive access; it is in knowing which Japanese sources contain the most material information and surfacing them for English-reading investors who would otherwise miss them.

How to Buy Advantest (6857) as an International Investor

Advantest trades on the Tokyo Stock Exchange Prime Market under ticker 6857. There is no sponsored ADR program internationally, so investors must access the stock via direct TSE trading through a broker with Japan market coverage.

International investors can access 6857 directly through:

• Saxo Bank — full TSE coverage, available in Singapore, Japan, Europe, and most countries. Strong platform for Japan equity access. Preferred broker for our Singapore/Asia-based readers.
• Interactive Brokers (IBKR) — direct TSE access, competitive JPY/USD spread, available in US and most countries. Strong choice for US-based investors and the most straightforward path to 6857 from a US brokerage account.
• Webull — lower minimums, growing TSE coverage, good for smaller position sizes (US audience). Verify current TSE availability directly with Webull before opening a position.

Tax notes by country:

• Singapore: No capital gains tax on Japan stocks. Japanese dividends are subject to 20.315% withholding (15% when the Japan-Singapore tax treaty applies via your broker). Net dividend received after withholding — check with your broker on treaty reclaim procedures.
• United States: Japanese dividend withholding is 15% under the US-Japan tax treaty; claimable as a foreign tax credit on IRS Form 1116. At Advantest’s current ~0.39% yield, the absolute withholding amount is modest, but the credit mechanism matters more if the payout ratio increases in future years.
• Other countries: Withholding rates vary by treaty. Check Japan’s National Tax Agency treaty list or consult your broker.

Account opening eligibility varies by country of residence. I am not affiliated with these brokers; this is general information only. Always verify current terms directly with the broker.

Disclaimer: This article is published in compliance with FTC 16 CFR Part 255. Opinions expressed are my own and do not constitute investment advice. I may or may not hold positions in Advantest (6857) at the time of publication. All financial data is sourced from public disclosures and third-party databases; verify independently before making investment decisions. Past performance does not guarantee future results. Currency fluctuations between JPY and USD can materially affect returns for non-Japanese investors. This content is intended for informational purposes only. Full Disclaimer available on the site. As of May 2026.